Important: Formulation and dosage details
Formulation:
Tablets 8mg, 16mg
Dosage:
Vertigo, tinnitus and hearing loss associated with Ménière’s disease, initially 16mg 3 times daily, maintenance 24 to 48mg daily in divided doses.
test announcement
Ménière’s is a disease causing attacks of disabling dizziness associated with transient loss of hearing and tinnitus. Betahistine is used specifically for Ménière’s however is of no benefit in other sorts of imbalance. For further information refer to Dizziness guidance.